OWC Pharmaceutical Research (OWC Pharmaceutical Research) Inventory-to-Revenue : 0.00 (As of Sep. 2019)

View and export this data going back to 2008. Start your Free Trial

What is OWC Pharmaceutical Research Inventory-to-Revenue?

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. OWC Pharmaceutical Research's Average Total Inventories for the quarter that ended in Sep. 2019 was $0.00 Mil. OWC Pharmaceutical Research's Revenue for the three months ended in Sep. 2019 was $0.00 Mil.

OWC Pharmaceutical Research's Inventory-to-Revenue for the quarter that ended in Sep. 2019 stayed the same from Jun. 2019 (0.00) to Jun. 2019 (0.00)

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory Turnover measures how fast the company turns over its inventory within a year.

OWC Pharmaceutical Research Inventory-to-Revenue Historical Data

The historical data trend for OWC Pharmaceutical Research's Inventory-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OWC Pharmaceutical Research Inventory-to-Revenue Chart

OWC Pharmaceutical Research Annual Data

Trend

Dec08

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Inventory-to-Revenue

Get a 7-Day Free Trial

OWC Pharmaceutical Research Quarterly Data
	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19
Inventory-to-Revenue	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of OWC Pharmaceutical Research's Inventory-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, OWC Pharmaceutical Research's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

OWC Pharmaceutical Research's Inventory-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, OWC Pharmaceutical Research's Inventory-to-Revenue distribution charts can be found below:

* The bar in red indicates where OWC Pharmaceutical Research's Inventory-to-Revenue falls into.

OWC Pharmaceutical Research Inventory-to-Revenue Calculation

OWC Pharmaceutical Research's Inventory-to-Revenue for the fiscal year that ended in Dec. 2018 is calculated as

	Inventory-to-Revenue (A: Dec. 2018 )
=	Average Total Inventories					/	Revenue
=	( (Total Inventories (A: Dec. 2017 )	+	Total Inventories (A: Dec. 2018 ))	/	count )	/	Revenue (A: Dec. 2018 )
=	( (0	+	0)	/	1 )	/	0
=	0					/	0
=	N/A

OWC Pharmaceutical Research's Inventory-to-Revenue for the quarter that ended in Sep. 2019 is calculated as

	Inventory-to-Revenue (Q: Sep. 2019 )
=	Average Total Inventories					/	Revenue
=	( (Total Inventories (Q: Jun. 2019 )	+	Total Inventories (Q: Sep. 2019 ))	/	count )	/	Revenue (Q: Sep. 2019 )
=	( (0	+	0)	/	1 )	/	0
=	0					/	0
=

OWC Pharmaceutical Research (OTCPK:OWCP) Inventory-to-Revenue Explanation

An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:

1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.

Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:

1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.

More Related Terms:

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

OWC Pharmaceutical Research's Days Inventory for the three months ended in Sep. 2019 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Sep. 2019 )	/	Cost of Goods Sold (Q: Sep. 2019 )	*	Days in Period
	=	0	/	0	*	365 / 4
	=

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

OWC Pharmaceutical Research's Inventory Turnover for the quarter that ended in Sep. 2019 is calculated as

Inventory Turnover	=	Cost of Goods Sold (Q: Sep. 2019 )	/	Average Total Inventories (Q: Sep. 2019 )
	=	0	/	0
	=

OWC Pharmaceutical Research Inventory-to-Revenue Related Terms

Thank you for viewing the detailed overview of OWC Pharmaceutical Research's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

OWC Pharmaceutical Research (OWC Pharmaceutical Research) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » OWC Pharmaceutical Research Corp (OTCPK:OWCP) » Definitions » Inventory-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

2 Ben Gurion Street, Ramat Gan, ISR, 5257334

Website

http://www.owcpharma.com

OWC Pharmaceutical Research Corp is a medical cannabis research and development company. The firm through its subsidiary researches and develops cannabis-based products and treatments specifically designed for multiple myeloma, psoriasis, fibromyalgia, post-traumatic stress disorder (PTSD), migraine, sexual function and skin disorders. It also provides consulting services to governmental and private entities to assist them with developing and implementing tailor-made medical cannabis program.

Executives

Asher Zwebner

director, officer: CHIEF FINANCIAL OFFICER

CDOOR CORPORATION, 20 A REHOV SHAREI TORAH BAYIT VEGAN, JERUSALEM L3 96387